StrideBio is a gene therapy company focused on developing genetic medicines with curative potential for patients with devastating conditions. It leverages its proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform to create unique and differentiated vectors that improve upon naturally occurring AAV serotypes to overcome current limitations of first-generation gene therapies. The company was founded in 2015 and is headquartered in Durham, North Carolina.

IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions. IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Wuxi Hanqiang Pharmaceutical Technology Co., Ltd., established on 2007-11-16, Business scope includes technology development of medicine,technology transfer,Technical Services;marketing planning;Nutrition and Health Consulting(Does not contain medical properties),beauty consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system (CNS). It is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. The company’s initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS), and Friedreich’s ataxia.

Microbiotix, Inc. is an American private company located in Worcester, MA, involved in pharmaceutical preparations. The firm was founded by Wendy E. Rieder.\nOn its website, the company says this about itself: Microbiotix is a Worcester, MA-based biotech company focused on the discovery and development of novel drugs that target serious infectious diseases and multi-drug resistant pathogens. The Company's lead program, MBX-400, a novel, potent nucleoside dual DNA polymerase/kinase inhibitor for the management of cytomegalovirus (CMV) disease in transplant patients, is Phase 2-ready.

Neogenix Oncology is a clinical stage bio-therapeutics company that focuses on developing novel therapeutic and diagnostic products for the treatment of pancreatic, colon, lung, prostate, and various other cancers. Its primary product, NEO-101, is a novel Phase II monoclonal antibody for colorectal and pancreatic cancer indications. Neogenix Oncology’s product pipeline also includes NEO-201 and NEO-301, which are preclinical monoclonal antibodies for the treatment of pancreatic and colorectal cancers. The company also has a research collaboration agreement with San Raffaele-Pisana to study the expression of tumor-specific biomarkers using NEO-101, NEO-201, and NEO-301 therapeutic programs. Headquartered in Great Neck, New York, Neogenix Oncology was founded in 2003.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Institut de Recherche pour le Développement operates as a scientific and technical public institution which provides information, expertise, support and training in production performance. It performs research centered on the relationship between human beings and its environment in intertropical areas. In that context the IRD implements research projects on sleeping sickness and the vectors transmitting the disease. The company is headquartered in Marseille, France.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Beijing Bioways Pharmaceutical Research Co., Ltd., established on 2016-01-22, The scope of business includes the sale of food;wholesale medicine;retail medicine;Medical Research and Experimental Development;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;technology development;technical consulting;Technical Services;technology transfer;software development;Organize cultural and artistic exchange activities(without show);Economic and Trade Consulting;Sales of machinery and equipment,Electrical Equipment,electronic product,Class Ι medical device,Class II Medical Devices,Instrumentation,computer,Software and Auxiliary Equipment,cosmetic;Import and export;Agent import and export;Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,wholesale medicine,Retail pharmaceuticals and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Secarna Pharmaceuticals Gmbh & Co. is a private company headquartered in Germany. The firm operates as drug discovery company.\nThe company says this about itself: Secarna Pharmaceuticals is the leading independent European next-generation antisense drug discovery and development company addressing high unmet medical needs in immuno-oncology, immunology, as well as viral, neurodegenerative and cardiometabolic diseases. Secarna's mission is to maximize the performance and output of its proprietary LNAplus TM antisense oligonucleotide discovery platform, as well as to develop highly specific, safe, and efficacious best-in-class antisense therapies. With over 15 development programs, including both proprietary pipeline projects and partnered programs, Secarna focuses on targets in indications where antisense-based approaches have clear potential benefits over other therapeutic modalities.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Kangyanbao (Beijing) Stem Cell Technology Co., Ltd., established on 2019-05-07, The scope of business includes the sale of food;retail medicine;Biotechnology Extension Services;Medical Research and Experimental Development;technology development,technical consulting,technology transfer,Technical Services;hospital management;Sales of biological reagents(Does not contain drugs,Free of Hazardous Chemicals);Quality and technical inspection.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Retail pharmaceuticals and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)